On April 14, 2022, the Minister of Health announced that the federal government would not implement the changes to the patented medicines regulations introducing new pharmaco-economic factors and requiring that information related to cost and revenues be disclosed. The federal government will move forward with the changes which use a new basket of comparative countries. These amendments are expected to come into force on July 1, 2022.

Read More